Skip to main content
FinSpry Logo
FinSpry
IMVT logo
IMVT
(NASDAQ)
Immunovant, Inc.
$24.50-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Immunovant (IMVT) Stock Price & Financial Analysis

Immunovant Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$23.24 - $25.37
52-Week High$29.25
52-Week Low$12.72
Open$23.76
Volume2.01M
Average Volume (3M)2.01M
Market Cap4.45B
Shares Outstanding181.51M
Price to Book (P/B)4.62
EV/EBITDA-7.32
50-Day MA$25.82
200-Day MA$21.13
52-Week Change65.13%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Immunovant

What is the current stock price for IMVT?

As of the latest trading session, IMVT stock trades at $24.50. The 52-week range is $12.72–$29.25, with a day range of $23.24–$25.37.

What is the P/E ratio for IMVT?

The P/E ratio (Price-to-Earnings) for IMVT is shown in the Key Statistics section. This valuation metric helps compare Immunovant, Inc. to industry peers.

Does IMVT pay dividends?

Immunovant does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IMVT?

Based on 4 analysts, the consensus for IMVT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IMVT?

Immunovant's market capitalization is $4.45B, classifying it as a mid-cap company. Immunovant operates in the Healthcare sector within the Biotechnology industry.